active
ACTIVE SINCE: 2013

GSK – Save the Children Partnership

Breaking new ground and finding new ways to bring down the number of children dying from preventable diseases.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
Global NGOs 1
Objectives

By combining the unique capabilities of GSK and Save the Children, GSK’s scientific and manufacturing expertise and Save the Children’s on-the-ground experience, we are finding new ways to help bring down the number of children dying from preventable and treatable diseases.

Every day, 15,000 children under the age of five die – most from preventable causes. That’s why Save the Children and GSK joined forces in 2013. By bringing together our unique skills and resources, we are breaking new ground and finding new ways to bring down the number of children dying from preventable diseases. GSK is a global expert in the research, development and supply of medicines and vaccinations. Save the Children has 100 years of experience in creating meaningful and lasting change for children and families across the world, helping more children to survive and thrive. Together we have built a pioneering and powerful partnership that is saving the lives of some of the world’s most vulnerable children.

We have already significantly helped to bring down the number of children dying from preventable deaths and have reached over 2.8 million children under five in 45 countries so far.

By delivering long-term health programmes, strengthening countries’ healthcare systems, finding new treatments and advocating for local, national and global change, we can help build a world where no child under the age of five dies from preventable causes.

Quote
"Over the past six years, our partnership has fought for children every single day, combining our skills to find new ways to reduce child mortality. We’ve reached over 2,800,000 children under five with essential health services."
Kevin Watkins
CEO – Save the Children UK
Results and milestones

2.8 million children under five in 45 countries helped so far including:

  • 30,000 newborns have benefitted from our new chlorhexidine gel developed within the partnership
  • 97,600 children fully immunised
  • 300,000 children helped during and after emergencies
  • 187,000 children treated for malaria, pneumonia or diarrhoea
  • over 20,000 healthworkers and 12,000 community health workers trained
  • Plus – GSK employees have raised £3.3 million since the start of the partnership in 2013 which has also been matched by GSK.
Geographic Reach
  • Global Commitment
Disease Area
  • Infectious and Parasitic Disease
  • Women’s and Child Health
  • Non-communicable diseases
See Disease Areas
Target Population
  • Children
  • Youth
  • Women
  • People with low incomes
  • Marginalized/indigenous people
  • Rural populations
SGDs the partnership contributes to
SDG 3: Good health and well-being
  1. 3.1: Reduce maternal mortality
  2. 3.2: Reduce under-5 mortality 
  3. 3.3: Communicable diseases and NTDs
  4. 3.4: NCDs (including mental health)
  5. 3.7: Access to sexual and reproductive health-care services 
  6. 3.8: Achieve universal health coverage
SDG 5: Gender equality
SDG 10: Reduced inequalities
SDG 17: Partnerships for the goals 
Partner organizations
Global NGOs
Save the
Children

Core role of this partner: Strategic, design, and implementation co-partner. Partner’s specific area of expertise: Access to health and improvement of health and Universal Health Coverage (UHC) for children, women, and the marginalised.